Abnormal GPAT activity is linked to various metabolic disorders. Overexpression of GPAT can lead to an accumulation of triglycerides, contributing to obesity and non-alcoholic fatty liver disease (NAFLD). Conversely, reduced GPAT activity can impair lipid synthesis, affecting membrane integrity and function. Research is ongoing to understand the exact mechanisms by which GPAT dysregulation contributes to these conditions.
